Fund Insights
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
High Conviction Trades
Discover high conviction trades that caused a significant change in a fund's stake in a stock
Fund Manager Portfolios
Gain insights from the world’s largest funds and super investors
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Search
Sign in
Sign up
MAP
MACK
Madison Avenue Partners’s
Merrimack Pharmaceuticals, Inc.
MACK
Stock Holding History
Madison Avenue Partners’s Portfolio
MACK Stock Details
MACK Fund Activity
Bought
Maintained
Sold
Quarter
Market Value
Status
Shares
Change in
Stake
Trade Value
Portfolio Weight
Portfolio Position
2024
Q2
–
Sell
-387,221
Closed
-$5.72M
–
24
2024
Q1
$5.72M
Sell
387,221
-165,864
-30%
-$2.33M
0.92%
14
2023
Q4
$7.42M
Hold
553,085
–
–
1.05%
14
2023
Q3
$6.82M
Hold
553,085
–
–
0.97%
10
2023
Q2
$6.8M
Hold
553,085
–
–
1.48%
11
2023
Q1
$6.8M
Buy
+553,085
New
+$6.5M
1.46%
14
Other funds holding MACK
Dimensional Fund Advisors
Austin, Texas
$481B AUM
30.42%
1-Year Est. Return
Goldman Sachs
New York
$761B AUM
31.28%
1-Year Est. Return
RhumbLine Advisers
Boston, Massachusetts
$117B AUM
29.66%
1-Year Est. Return
RA
Rise Advisors
Rochester, New York
$355M AUM
20.51%
1-Year Est. Return
JC
JBF Capital
Aspen, Colorado
$674M AUM
24.74%
1-Year Est. Return
Marshall Wace
London, United Kingdom
$93.4B AUM
35.1%
1-Year Est. Return
Sign up
Sign in
Fund Insights
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
High Conviction Trades
Discover high conviction trades that caused a significant change in a fund's stake in a stock
Fund Manager Portfolios
Gain insights from the world’s largest funds and super investors
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Theme
Close